Ampio pharmaceuticals to participate in the 33rd annual virtual roth conference on march 15-17, 2021

Englewood, colo., march 10, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that it has been invited to participate in the 33rd annual roth growth conference being held virtually on march 15-17, 2021.

AMPE Ratings Summary

AMPE Quant Ranking